0.012706 0.000000 0.006117 0.000000 0.015492 0.000000 0.000000 0.000000 0.028316 0.00000 0.00000 0.00000 Anand, K. Mesters, J.R. Goerlach, R. Zell, R. Hilgenfeld, R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 115.71 90.00 78.706 64.550 39.196 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking Cl -1 35.453 CHLORIDE ION non-polymer C5 H11 N O3 S2 197.276 n S,S-(2-HYDROXYETHYL)THIOCYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Crystal Structure of Coxsackie Virus B3 Proteinase 3C UK RNA RNARFU 2122 1355-8382 8 188 10.1017/S1355838202012785 11911365 Determinants of the Recognition of Enteroviral Cloverleaf RNA by Coxsackievirus B3 Proteinase 3C. 2002 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 MIRRORS CCD 2003-10-23 MARRESEARCH SINGLE WAVELENGTH M x-ray 1 0.804 1.0 X13 EMBL/DESY, HAMBURG 0.804 SYNCHROTRON EMBL/DESY, HAMBURG BEAMLINE X13 BETA-MERCAPTOETHANOL LINKED TO ACTIVE-SITE CYSTEINE 20374.410 POLYPROTEIN 3BCD 3.4.22.28 3C PROTEINASE, RESIDUES 14-196 1 man polymer 35.453 CHLORIDE ION 1 syn non-polymer 18.015 water 47 nat water COXSACKIEVIRUS B3 PROTEINASE 3C no yes GPAFEFAVAMMKRNSSTVKTEYGEFTMLGIYDRWAVLPRHAKPGPTILMNDQEVGVLDAKELVDKDGTNLELTLLKLNRN EKFRDIRGFLAKEEVEVNEAVLAINTSKFPNMYIPVGQVTEYGFLNLGGTPTKRMLMYNFPTRAGQ(CME)GGVLMSTGK VLGIHVGGNGHQGFSAALLKHYFNDEQ GPAFEFAVAMMKRNSSTVKTEYGEFTMLGIYDRWAVLPRHAKPGPTILMNDQEVGVLDAKELVDKDGTNLELTLLKLNRN EKFRDIRGFLAKEEVEVNEAVLAINTSKFPNMYIPVGQVTEYGFLNLGGTPTKRMLMYNFPTRAGQCGGVLMSTGKVLGI HVGGNGHQGFSAALLKHYFNDEQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n NANCY sample 103903 COXSACKIEVIRUS B3 511693 ESCHERICHIA COLI BL21 PET23A-3CSTOP 1 2.17 42.85 NONE 5.5 pH 5.5 diffrn_source pdbx_unobs_or_zero_occ_atoms struct_conn repository Initial release Source and taxonomy Version format compliance Advisory Data collection Derived calculations 1 0 2008-10-28 1 1 2011-07-13 1 2 2019-07-24 _diffrn_source.pdbx_synchrotron_site _struct_conn.pdbx_leaving_atom_flag SHEET DETERMINATION METHOD: DSSP THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS ARE IDENTICAL. THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS ARE IDENTICAL. PDBE Y PDBE 2007-09-05 REL CL CHLORIDE ION HOH water CL 1184 2 CL CL 1184 A HOH 2001 3 HOH HOH 2001 A HOH 2002 3 HOH HOH 2002 A HOH 2003 3 HOH HOH 2003 A HOH 2004 3 HOH HOH 2004 A HOH 2005 3 HOH HOH 2005 A HOH 2006 3 HOH HOH 2006 A HOH 2007 3 HOH HOH 2007 A HOH 2008 3 HOH HOH 2008 A HOH 2009 3 HOH HOH 2009 A HOH 2010 3 HOH HOH 2010 A HOH 2011 3 HOH HOH 2011 A HOH 2012 3 HOH HOH 2012 A HOH 2013 3 HOH HOH 2013 A HOH 2014 3 HOH HOH 2014 A HOH 2015 3 HOH HOH 2015 A HOH 2016 3 HOH HOH 2016 A HOH 2017 3 HOH HOH 2017 A HOH 2018 3 HOH HOH 2018 A HOH 2019 3 HOH HOH 2019 A HOH 2020 3 HOH HOH 2020 A HOH 2021 3 HOH HOH 2021 A HOH 2022 3 HOH HOH 2022 A HOH 2023 3 HOH HOH 2023 A HOH 2024 3 HOH HOH 2024 A HOH 2025 3 HOH HOH 2025 A HOH 2026 3 HOH HOH 2026 A HOH 2027 3 HOH HOH 2027 A HOH 2028 3 HOH HOH 2028 A HOH 2029 3 HOH HOH 2029 A HOH 2030 3 HOH HOH 2030 A HOH 2031 3 HOH HOH 2031 A HOH 2032 3 HOH HOH 2032 A HOH 2033 3 HOH HOH 2033 A HOH 2034 3 HOH HOH 2034 A HOH 2035 3 HOH HOH 2035 A HOH 2036 3 HOH HOH 2036 A HOH 2037 3 HOH HOH 2037 A HOH 2038 3 HOH HOH 2038 A HOH 2039 3 HOH HOH 2039 A HOH 2040 3 HOH HOH 2040 A HOH 2041 3 HOH HOH 2041 A HOH 2042 3 HOH HOH 2042 A HOH 2043 3 HOH HOH 2043 A HOH 2044 3 HOH HOH 2044 A HOH 2045 3 HOH HOH 2045 A HOH 2046 3 HOH HOH 2046 A HOH 2047 3 HOH HOH 2047 A GLY 1 n 1 GLY 1 A PRO 2 n 2 PRO 2 A ALA 3 n 3 ALA 3 A PHE 4 n 4 PHE 4 A GLU 5 n 5 GLU 5 A PHE 6 n 6 PHE 6 A ALA 7 n 7 ALA 7 A VAL 8 n 8 VAL 8 A ALA 9 n 9 ALA 9 A MET 10 n 10 MET 10 A MET 11 n 11 MET 11 A LYS 12 n 12 LYS 12 A ARG 13 n 13 ARG 13 A ASN 14 n 14 ASN 14 A SER 15 n 15 SER 15 A SER 16 n 16 SER 16 A THR 17 n 17 THR 17 A VAL 18 n 18 VAL 18 A LYS 19 n 19 LYS 19 A THR 20 n 20 THR 20 A GLU 21 n 21 GLU 21 A TYR 22 n 22 TYR 22 A GLY 23 n 23 GLY 23 A GLU 24 n 24 GLU 24 A PHE 25 n 25 PHE 25 A THR 26 n 26 THR 26 A MET 27 n 27 MET 27 A LEU 28 n 28 LEU 28 A GLY 29 n 29 GLY 29 A ILE 30 n 30 ILE 30 A TYR 31 n 31 TYR 31 A ASP 32 n 32 ASP 32 A ARG 33 n 33 ARG 33 A TRP 34 n 34 TRP 34 A ALA 35 n 35 ALA 35 A VAL 36 n 36 VAL 36 A LEU 37 n 37 LEU 37 A PRO 38 n 38 PRO 38 A ARG 39 n 39 ARG 39 A HIS 40 n 40 HIS 40 A ALA 41 n 41 ALA 41 A LYS 42 n 42 LYS 42 A PRO 43 n 43 PRO 43 A GLY 44 n 44 GLY 44 A PRO 45 n 45 PRO 45 A THR 46 n 46 THR 46 A ILE 47 n 47 ILE 47 A LEU 48 n 48 LEU 48 A MET 49 n 49 MET 49 A ASN 50 n 50 ASN 50 A ASP 51 n 51 ASP 51 A GLN 52 n 52 GLN 52 A GLU 53 n 53 GLU 53 A VAL 54 n 54 VAL 54 A GLY 55 n 55 GLY 55 A VAL 56 n 56 VAL 56 A LEU 57 n 57 LEU 57 A ASP 58 n 58 ASP 58 A ALA 59 n 59 ALA 59 A LYS 60 n 60 LYS 60 A GLU 61 n 61 GLU 61 A LEU 62 n 62 LEU 62 A VAL 63 n 63 VAL 63 A ASP 64 n 64 ASP 64 A LYS 65 n 65 LYS 65 A ASP 66 n 66 ASP 66 A GLY 67 n 67 GLY 67 A THR 68 n 68 THR 68 A ASN 69 n 69 ASN 69 A LEU 70 n 70 LEU 70 A GLU 71 n 71 GLU 71 A LEU 72 n 72 LEU 72 A THR 73 n 73 THR 73 A LEU 74 n 74 LEU 74 A LEU 75 n 75 LEU 75 A LYS 76 n 76 LYS 76 A LEU 77 n 77 LEU 77 A ASN 78 n 78 ASN 78 A ARG 79 n 79 ARG 79 A ASN 80 n 80 ASN 80 A GLU 81 n 81 GLU 81 A LYS 82 n 82 LYS 82 A PHE 83 n 83 PHE 83 A ARG 84 n 84 ARG 84 A ASP 85 n 85 ASP 85 A ILE 86 n 86 ILE 86 A ARG 87 n 87 ARG 87 A GLY 88 n 88 GLY 88 A PHE 89 n 89 PHE 89 A LEU 90 n 90 LEU 90 A ALA 91 n 91 ALA 91 A LYS 92 n 92 LYS 92 A GLU 93 n 93 GLU 93 A GLU 94 n 94 GLU 94 A VAL 95 n 95 VAL 95 A GLU 96 n 96 GLU 96 A VAL 97 n 97 VAL 97 A ASN 98 n 98 ASN 98 A GLU 99 n 99 GLU 99 A ALA 100 n 100 ALA 100 A VAL 101 n 101 VAL 101 A LEU 102 n 102 LEU 102 A ALA 103 n 103 ALA 103 A ILE 104 n 104 ILE 104 A ASN 105 n 105 ASN 105 A THR 106 n 106 THR 106 A SER 107 n 107 SER 107 A LYS 108 n 108 LYS 108 A PHE 109 n 109 PHE 109 A PRO 110 n 110 PRO 110 A ASN 111 n 111 ASN 111 A MET 112 n 112 MET 112 A TYR 113 n 113 TYR 113 A ILE 114 n 114 ILE 114 A PRO 115 n 115 PRO 115 A VAL 116 n 116 VAL 116 A GLY 117 n 117 GLY 117 A GLN 118 n 118 GLN 118 A VAL 119 n 119 VAL 119 A THR 120 n 120 THR 120 A GLU 121 n 121 GLU 121 A TYR 122 n 122 TYR 122 A GLY 123 n 123 GLY 123 A PHE 124 n 124 PHE 124 A LEU 125 n 125 LEU 125 A ASN 126 n 126 ASN 126 A LEU 127 n 127 LEU 127 A GLY 128 n 128 GLY 128 A GLY 129 n 129 GLY 129 A THR 130 n 130 THR 130 A PRO 131 n 131 PRO 131 A THR 132 n 132 THR 132 A LYS 133 n 133 LYS 133 A ARG 134 n 134 ARG 134 A MET 135 n 135 MET 135 A LEU 136 n 136 LEU 136 A MET 137 n 137 MET 137 A TYR 138 n 138 TYR 138 A ASN 139 n 139 ASN 139 A PHE 140 n 140 PHE 140 A PRO 141 n 141 PRO 141 A THR 142 n 142 THR 142 A ARG 143 n 143 ARG 143 A ALA 144 n 144 ALA 144 A GLY 145 n 145 GLY 145 A GLN 146 n 146 GLN 146 A CME 147 n 147 CME 147 A GLY 148 n 148 GLY 148 A GLY 149 n 149 GLY 149 A VAL 150 n 150 VAL 150 A LEU 151 n 151 LEU 151 A MET 152 n 152 MET 152 A SER 153 n 153 SER 153 A THR 154 n 154 THR 154 A GLY 155 n 155 GLY 155 A LYS 156 n 156 LYS 156 A VAL 157 n 157 VAL 157 A LEU 158 n 158 LEU 158 A GLY 159 n 159 GLY 159 A ILE 160 n 160 ILE 160 A HIS 161 n 161 HIS 161 A VAL 162 n 162 VAL 162 A GLY 163 n 163 GLY 163 A GLY 164 n 164 GLY 164 A ASN 165 n 165 ASN 165 A GLY 166 n 166 GLY 166 A HIS 167 n 167 HIS 167 A GLN 168 n 168 GLN 168 A GLY 169 n 169 GLY 169 A PHE 170 n 170 PHE 170 A SER 171 n 171 SER 171 A ALA 172 n 172 ALA 172 A ALA 173 n 173 ALA 173 A LEU 174 n 174 LEU 174 A LEU 175 n 175 LEU 175 A LYS 176 n 176 LYS 176 A HIS 177 n 177 HIS 177 A TYR 178 n 178 TYR 178 A PHE 179 n 179 PHE 179 A ASN 180 n 180 ASN 180 A ASP 181 n 181 ASP 181 A GLU 182 n 182 GLU 182 A GLN 183 n 183 GLN 183 A author_and_software_defined_assembly PQS 2 dimeric 1510 -16.0 20120 A CME 147 S,S-(2-HYDROXYETHYL)THIOCYSTEINE A CME 147 CYS 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 2_555 -x,y,-z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 A N THR 20 A N THR 20 A O GLY 23 A O GLY 23 A N ILE 30 A N ILE 30 A O TRP 34 A O TRP 34 A N LEU 37 A N LEU 37 A O THR 73 A O THR 73 A N ASN 78 A N ASN 78 A O GLY 55 A O GLY 55 A N VAL 54 A N VAL 54 A O ILE 47 A O ILE 47 A N LEU 48 A N LEU 48 A O LYS 19 A O LYS 19 A N ILE 104 A N ILE 104 A O MET 112 A O MET 112 A N LEU 127 A N LEU 127 A O THR 130 A O THR 130 A N TYR 138 A N TYR 138 A O GLY 169 A O GLY 169 A N ALA 172 A N ALA 172 A O ILE 160 A O ILE 160 A N LEU 158 A N LEU 158 A O LEU 151 A O LEU 151 A N MET 152 A N MET 152 A O VAL 101 A O VAL 101 1 A A NE2 SD HIS CME 40 147 2.19 1 -22.05 1.50 103.20 81.15 A A A N CD CG PRO PRO PRO 2 2 2 N 1 19.88 2.60 111.60 131.48 A A A CB CG CD LYS LYS LYS 60 60 60 N 1 14.26 2.30 115.30 129.56 A A A CA CB CG LEU LEU LEU 75 75 75 N 1 3.04 0.50 120.30 123.34 A A A NE CZ NH1 ARG ARG ARG 79 79 79 N 1 -3.30 0.50 120.30 117.00 A A A NE CZ NH2 ARG ARG ARG 79 79 79 N 1 -12.00 2.00 110.40 98.40 A A A CB CA C LYS LYS LYS 108 108 108 N 1 21.85 1.80 110.60 132.45 A A A N CA CB LYS LYS LYS 108 108 108 N 1 A A CG CD PRO PRO 2 2 0.249 0.033 1.502 1.751 N 1 A A CD N PRO PRO 2 2 0.358 0.014 1.474 1.832 N 1 A ASP 32 51.66 -109.79 1 A LYS 42 36.53 57.98 1 A ASP 51 53.75 15.35 1 A THR 106 -107.19 -158.12 1 A ASN 111 36.58 63.53 1 A GLU 121 -65.35 94.41 1 A PRO 141 -54.57 94.25 1 A ARG 143 -170.42 147.45 1 A SER 153 -129.73 -167.54 1 A ASP 181 -34.48 105.03 1 A GLU 182 64.40 -133.74 47.96 0.27000 0.00000 -0.25000 -0.30000 0.00000 -0.19000 0.938 0.896 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 0.266 0.207 0.210 2.40 35.36 330 6582 4.800 99.1 9.986 0.244 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 0.715 0.307 0.80 0.80 1.20 HAV 3CPRO MAXIMUM LIKELIHOOD BABINET MODEL WITH MASK 2.40 35.36 47 1477 1 0 1429 0.017 0.022 1447 1.837 1.969 1954 8.337 5.000 182 36.931 24.394 66 19.531 15.000 243 18.069 15.000 8 0.124 0.200 213 0.007 0.020 1104 0.237 0.200 633 0.314 0.200 935 0.192 0.200 83 0.222 0.200 32 0.227 0.200 3 0.937 1.500 931 1.568 2.000 1444 2.216 3.000 584 3.044 4.500 510 0.3230 0.2420 2.46 26 427 20 2.40 35.36 2VB0 6931 -3.0 0.11 1 11.95 5.1 99.7 0.40 2.40 2.46 4.00 1 97.4 refinement REFMAC 5.3.0037 data reduction DENZO data scaling SCALEPACK phasing EPMR POLYPROTEIN 3BCD (E.C.3.4.22.28) Crystal structure of coxsackievirus B3 proteinase 3C 1 N N 2 N N 3 N N A GLY 1 A GLY 1 HELX_P A ASN 14 A ASN 14 1 1 14 A HIS 40 A HIS 40 HELX_P A LYS 42 A LYS 42 5 2 3 A ILE 86 A ILE 86 HELX_P A LEU 90 A LEU 90 5 3 5 A LEU 175 A LEU 175 HELX_P A ASN 180 A ASN 180 5 4 6 covale 1.337 both A GLN 146 A C GLN 146 1_555 A CME 147 A N CME 147 1_555 covale 1.326 both A CME 147 A C CME 147 1_555 A GLY 148 A N GLY 148 1_555 HYDROLASE CHYMOTRYPSIN-LIKE FOLD, AG7088, RNA-BINDING PROTEIN, PICORNAVIRIDAE, CYSTEINE PROTEASE, HUMAN ENTEROVIRUS B, HYDROLASE Q90092_9ENTO UNP 1 Q90092 14 196 2VB0 1 183 Q90092 A 1 1 183 8 8 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A SER 15 A SER 15 A THR 20 A THR 20 A GLY 23 A GLY 23 A TYR 31 A TYR 31 A TRP 34 A TRP 34 A PRO 38 A PRO 38 A ASN 69 A ASN 69 A ASN 78 A ASN 78 A GLU 53 A GLU 53 A VAL 63 A VAL 63 A THR 46 A THR 46 A MET 49 A MET 49 A SER 15 A SER 15 A THR 20 A THR 20 A SER 15 A SER 15 A THR 20 A THR 20 A VAL 97 A VAL 97 A ILE 104 A ILE 104 A MET 112 A MET 112 A LEU 127 A LEU 127 A THR 130 A THR 130 A ASN 139 A ASN 139 A GLN 168 A GLN 168 A ALA 173 A ALA 173 A LYS 156 A LYS 156 A GLY 164 A GLY 164 A VAL 150 A VAL 150 A SER 153 A SER 153 A VAL 97 A VAL 97 A ILE 104 A ILE 104 A VAL 97 A VAL 97 A ILE 104 A ILE 104 BINDING SITE FOR RESIDUE CL A1184 Software 4 A ASP 85 A ASP 85 4 1_555 A ILE 86 A ILE 86 4 1_555 A ARG 87 A ARG 87 4 1_555 A GLY 88 A GLY 88 4 1_555 5 C 1 2 1